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Abstract 
Background: Prevalence of lymphatic filariasis (LF) antigen in American Samoa was 16.5% in 1999. Seven rounds 
of mass drug administration (MDA) programmes between 2000 and 2006 reduced antigen prevalence to 2.3%. The 
most efficient methods of surveillance after MDA are not clear, but testing specific at-risk groups such as adults may 
provide earlier warning of resurgence. The role of migration from LF endemic countries in maintaining transmission 
also needs investigation. Few studies have investigated knowledge about LF and how that relates to infection risk. 
This study aims to investigate associations between socio-demographics, population mobility, disease knowledge 
and LF infection risk.
Methods: In 2014, we surveyed 670 adults aged 16–68 years (62% female) at two worksites in American Samoa. Sera 
were tested for LF antigen and antibodies (Bm14 and Wb123) by rapid test and/or ELISA. Multivariate logistic regres-
sion was used to assess association between seromarkers and demographic factors, household socioeconomic status 
(SES), residence, travel history, and knowledge of LF.
Results: Overall, 1.8% of participants were positive for antigen, 11.8% for Bm14, 11.3% for Wb123 and 17.3% for at 
least one antibody. Recent travel outside American Samoa was not associated with positivity for any seromarker. Men 
had higher seroprevalence than women for all outcomes (any antibody: adjusted odds ratio (aOR) = 3.49 (95% CI: 
2.21–5.49). Those aged over 35 years (compared to 15–24 years) had higher prevalence of Bm14 antibody (aOR = 3.75, 
3.76 and 4.17 for ages 35–44, 45–54 and ≥ 55 years, respectively, P < 0.05). Lower SES was associated with seroposi-
tivity (antigen: aOR = 2.89, 95% CI: 1.09–7.69; either antibody: aOR = 1.51, 95% CI: 1.12–2.05). Those who knew that 
mosquitoes transmitted LF had lower Wb123 antibody prevalence (aOR = 0.55, 95% CI: 0.32–0.95).
Conclusions: Opportunistic sampling of adults at worksites provided an efficient and representative way to assess 
prevalence and risk factors for LF in American Samoa and in hindsight, foreshadowed the resurgence of transmis-
sion. Risk of LF infection, detected by one or more serological markers, was not related to recent travel history, but 
was strongly associated with male gender, older age, lower SES, and lack of knowledge about mosquito transmission. 
These results could guide future efforts to increase MDA participation.
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Background
American Samoa is a US territory in the South Pacific 
Ocean. The population was estimated at 61,181 in 2014 
[1]. There are close family and cultural ties to nearby 
Samoa (formerly Western Samoa) with extensive and fre-
quent movement of people in both directions for short- 
and long-term visits [2], as well as to and from Hawaii 
and mainland USA.
American Samoa is known to have had a very high 
prevalence of lymphatic filariasis (LF) in the past [3]. This 
disease is caused by Wuchereria bancrofti worms which 
reside in the lymph system, where adult worms live for 
around five years and, if mated, produce microfilariae 
(Mf) that circulate in peripheral blood. Damage to the 
lymphatic system can result in lymphoedema and scro-
tal hydrocoele. In American Samoa, LF is classified as 
‘diurnally sub-periodic’ (Mf are present in the peripheral 
blood at all times, but at higher density in the daytime) 
and is transmitted by Aedes mosquitoes, mainly the day-
biting Aedes polynesiensis and also other potential day- 
and night-biting vectors [4, 5].
Control efforts using mass administration of diethyl-
carbamazine (DEC) started in American Samoa in 1962 
[6], but were not consistently applied, and did not elimi-
nate transmission of the disease. The Global Programme 
to Eliminate LF (GPELF) began in 2000, under auspices of 
the Pacific Programme for the Elimination of Lymphatic 
Filariasis (PacELF), offering mass drug administration 
(MDA) with diethylcarbamazine (DEC) and albendazole 
to everyone over two years of age (excluding pregnant 
women and the very ill) annually for at least five years [7].
Current guidelines for surveillance under the GPELF 
call for three sequential Transmission Assessment Sur-
veys (TAS) in children aged 6–7 years, with at least two 
years between surveys [8]. The first TAS is used to deter-
mine whether MDA can be stopped, and the subsequent 
TAS are intended to confirm that transmission has been 
interrupted, if the number of positive children is below a 
threshold corresponding to 2% prevalence where Anoph-
eles or Culex is the principal vector, and 1% if Aedes is the 
main vector. American Samoa’s LF programme predated 
the WHO 2011 guidelines [8] and the territory was fol-
lowing previous global and PacELF guidelines [3].
The recommended test for LF infection in W. bancrofti 
areas at the time of this study was the rapid Alere ICT 
(www.alere .com), which detects circulating antigen from 
adult worms [8]. In American Samoa, daytime blood 
films can also be used to detect Mf, which are present in a 
proportion of antigen positive individuals. Mf are cleared 
rapidly after effective treatment while antigen persists for 
many months or years; hence the focus on young children 
in TAS to detect recent infections. Antibody tests using 
Bm14 or Wb123 antibodies are also under consideration 
as potential surveillance markers [9], but they also persist 
for an uncertain period (many years) after treatment.
A seroprevalence survey in American Samoa in 2000 
demonstrated an antigen prevalence of 16.5% (using 
Binax Now, a precursor to Alere ICT), which had 
declined to 2.3% in 2007 after seven rounds of MDA 
[10]. However, transmission was not interrupted and 
new infections continued to occur in both children and 
adults, as shown by subsequent research surveys in 2010 
[11], 2014 [12] and 2016 [13], and by TAS conducted as 
part of programmatic activities in 2011, 2015 and 2016 [9, 
13]. The persistent high prevalence in 2016, the presence 
of hotspots of transmission, and apparent resurgence of 
infection rates has led to the use of the new triple drug 
strategy (ivermectin, DEC and albendazole, or IDA), with 
the first round distributed in 2018. The triple drug strat-
egy was recently recommended by the WHO for coun-
tries that have not achieved elimination targets despite 
conducting required numbers of MDA rounds [14].
LF is a heterogeneous disease with regard to gender, 
age and geographical distribution [11, 15–18]. Exposure 
to mosquitoes varies greatly depending on proximity to 
larval habitats, rainfall and temperature (for which alti-
tude may be a proxy). Culturally, people in the Pacific 
Islands generally spend a significant amount of time out-
doors and have close contact with their environment. 
While the vectors have a short flight range, people in 
American Samoa, as in other Pacific Islands, are highly 
mobile, both on a daily commuting basis to work at major 
employers [2] and to Samoa, other Pacific Islands and the 
USA, especially Hawaii. Other potential risk factors, such 
as population or household size and density, income/
socioeconomic status, or work location (indoor or out-
door) [11] are not well studied. Although most people in 
American Samoa live in improved housing supplied with 
electricity, toilets and running water, there is variation 
in living conditions, type of sanitation, screening of win-
dows and use of mosquito nets. Despite the longstanding 
presence of LF disease in American Samoa, it is not clear 
how much people know about the disease, or whether 
educational level or disease knowledge is associated with 
infection.
In 2014, we conducted a survey of LF infection in 
American Samoa in suspected hotspots, a school and 
worksites. Initial sero-epidemiological results of this 
study have been previously reported [12] in the context 
of confirming hotspots. Using data from the survey in 
worksites only, the present study aims to investigate the 
influence of previously uncharacterized socioeconomic 
status, education, work location, population mobility and 
knowledge of LF on the risk of LF infection.
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Methods
Study location
American Samoa consists of 7 tropical islands and 
islets, with the main island Tutuila comprising 58 
square miles (150  km2). From 2005 to 2015, annual 
rainfall ranged from 297 to 381  cm and average tem-
perature was between 27.3–28.5 °C [1]. The wet tropical 
environment and resulting high density of mosqui-
toes [19] leads to high risk of vector-borne diseases; 
dengue seroprevalence was over 95% in 2010 [20] and 
there are frequent outbreaks of arboviral diseases [21, 
22]. The population, estimated at 61,181 in 2014 [1] 
declined between 2000 and 2010 at an estimated annual 
rate of − 3.1%. The median age in the 2010 census was 
22.4  years and the estimated per capita income was 
USD 6311 [1]. Major income sources are tuna canning 
and government services. More than 40% of the resi-
dent American Samoa population were born overseas 
(30% in Samoa and 6% in USA), and for over half of the 
population, both parents were born overseas [1]. Two-
thirds of the population are either citizens or nationals 
of the USA who can travel there freely. Although Amer-
ican Samoa is geographically isolated, the population 
is highly mobile and travel frequently to visit family 
and friends, and for work, study and recreation. How-
ever, most families live on ancestral land, and perma-
nent relocations within the territory are relatively rare 
[2]. American Samoa is divided administratively into 9 
counties, each consisting of several villages [23].
Study design
The study was conducted between July and Novem-
ber 2014 in Tutuila, American Samoa, where > 95% of 
the population live. Adults (n = 498) of working age 
(aged ≥ 16 years) were recruited from Starkist tuna can-
nery (at that time, the largest private employer in the 
territory) over four days in October 2014. A further 
172 adults were recruited from a Department of Health 
(DOH) clinic where workers attend for fitness-for-
work medical examinations, on 14 clinic dates (8  days 
between July 2 and August 15, 2014 and a further 6 days 
in November 2014). At both locations, convenience 
sampling was used, and participation was optional after 
informed written consent. Cannery workers attended 
during their breaks; DOH clinic attendees were invited to 
participate following routine employment checks. Inter-
views were conducted in Samoan or English according 
to participant preference, using locally appropriate terms 
for diseases and symptoms.
Apart from demographic characteristics and educa-
tional level achieved, participants were asked about vil-
lage of residence, household location and characteristics, 
duration of residence in American Samoa, travel history 
outside of American Samoa in past 12 months, and host-
ing overnight visitors from Samoa in the past 12 months. 
They were also asked about knowledge of symptoms and 
causes of LF, history of taking MDA either in American 
Samoa or elsewhere and whether they had previously 
been diagnosed with LF.
Socioeconomic status index
Most residents of American Samoa live in houses made 
of solid (block or wood) construction with electricity 
and toilets. A small proportion of households consist of 
traditional open buildings without walls (‘fales’). People 
in more conventional households may also have ‘fales’ 
where they spend time during the day and evening. 
Since participants in this survey were not interviewed at 
home, and their houses could not be directly observed, 
we developed an index measure of socioeconomic status 
based on data obtained through interviews. A household 
wealth index was constructed using the methods of Vyas 
& Kumaranayake [24], employing principal components 
analysis to group households according to similarity in 
their scores on nine variables: possession of assets (tele-
vision, ceiling fan, air conditioning, mosquito nets (any)); 
plumbing (indoor toilet, indoor shower); household char-
acteristics (screens on windows); and services (piped hot 
water, garbage collection). The value of the first principal 
component produced by the analysis for each household 
was used to generate the asset index, which was then 
divided into three quantiles.
Participants were also asked about the household com-
bined yearly income. Due to missing data (i.e. people not 
knowing or choosing not to disclose their income), the 
income variable was not used directly; however, corre-
lation between this income estimate and the asset index 
was investigated to validate use of the quantiles of asset 
index in the regression.
Seroprevalence of antigen and antibody
Venous blood samples were taken from all participants, 
and tested by Alere ICT (www.alere .com; Brisbane, Aus-
tralia) for circulating filarial antigen. If the ICT test was 
positive or invalid it was repeated. All persons who tested 
positive for antigen were treated with DEC and alben-
dazole according to age as per WHO and DOH guide-
lines. Blood slides (3 lines per slide × 20  µl) were made 
from those who tested ICT positive. Blood samples were 
allowed to clot, spun at 2000×g for 10 min the same day 
and the serum decanted and frozen at − 20  °C or lower 
before transport to Australia.
Serological tests were performed on serum for antigen 
[Og4C3 ELISA (TropBio, Cellabs, Sydney, Australia)] and 
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antibodies [Bm14 ELISA (Cellabs) and Wb123 (in-house 
NIH assay or InBios (InBios International Inc., Seattle, 
WA, USA) ELISAs] as previously described by Lau et al. 
[11, 12]. All ELISAs included a standard curve; we used 
positive cut-offs of 32 units for Og4C3 antigen, 125 units 
for Bm14 and 70 units for Wb123 antibody. A person was 
classified as antigen-positive if positive for either ICT or 
Og4C3 or both; as antibody-positive if positive for either 
Bm14 or Wb123 or both; and as ‘any positive’ if positive 
for any antigen or antibody.
Data analysis
Questionnaire data were entered into Qualtrics soft-
ware (www.qualt rics.com, Sydney, Australia), cleaned, 
merged with serological results and imported into Stata 
14 (StataCorp, College Station, TX, USA) for descriptive 
analysis using Chi-square or Fisher’s exact tests of pro-
portions and logistic regression of risk factors associated 
with antigen or antibody positivity.
Four outcomes were used as markers of positivity for 
LF infection: antigen; Bm14 antibody; Wb123 antibody; 
and ‘any antibody’. Any risk factor showing significant 
association with any outcome at P < 0.2 was tested using 
multivariate logistic regression and retained if P remained 
< 0.2. County of residence was included as a fixed effect to 
investigate the role of unmeasured geographical or other 
factors. Variables with P ≥ 0.2 were sequentially manually 
removed from the multivariate logistic regression models 
to arrive at the best-fit and most parsimonious models. 
Non-significant variables (P ≥ 0.2) were retained in the 
models if they improved model fit; age-group and resi-
dence time were retained in most models.
Three models were tested: MODEL A with the 
most complete data after assigning knowledge vari-
ables to negative if the participant had not heard of 
LF (n = 639–642 depending on outcome); MODEL B 
with sociodemographic and residence/travel variables 
only (n = 639–642); MODEL C with all variables, but 
restricted to those who reported having heard of LF 
(n = 537–538). All models were tested with and with-
out inclusion of county as a fixed effect to account for 
unmeasured geographical variation.
Results
Questionnaire data including socioeconomic and travel 
data were obtained for 496 of 498 cannery workers 
and 150 of 172 participants from the DOH clinic (total 
n = 646). There were 25 participants with missing data 
on gender (2/498 at the cannery and 23/172 at the DOH 
clinic). Job status in the last 12 months was available for 
only 76/172 of the DOH clinic attendees.
Antigen, microfilaria and antibody positivity
Overall, 1.6% (10) of 670 participants tested by ICT were 
positive, 1.5% (10) of 666 tested were positive by Og4C3 
and 12 persons (1.8%) were positive by ICT and/or 
Og4C3 antigen (Fig. 1a and Table 1). Antigen prevalence 
was 1.6% in the cannery workers and 2.3% in the clinic 
attendees. Slides were available from 8 (age range 24–53 




























Fig. 1 Number of positives in adult workers for a ICT and Og4C3 antigen, and b Bm14 Ab, Wb123 Ab and antigen
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ICT-positive (Fig. 1b); one female aged 29 years was Mf-
positive with 2667 Mf/ml.
Seroprevalence of Bm14 and Wb123 antibodies were 
11.9% (79/666) and 11.3% (75/666), respectively (Fig. 1b 
and Table 1). Overall, 17.3% of participants (115 of 666) 
were positive for at least one antibody, and 17.6% (117 
of 666) were positive for at least one of the three sero-
markers. Two people were positive for antigen but not 
antibody. There was no statistically significant difference 
in antigen, Bm14 or Wb123 antibody prevalence by sam-
pling site (cannery or clinic).
Demographic characteristics
Gender and age
The prevalence of both antigen and antibody was 
lower in females than males in all age groups (Fig.  2). 
This difference was statistically significant for antibod-
ies (Table 2). Because females were overrepresented in 
the sample compared to the general population (61.7% 
in sample vs 49.9% in the population [1]), the gender-
adjusted prevalence of antigen was higher at 2.0% than 
the crude prevalence of 1.8%.
Mean age for all participants was 40.0 years (95% CI: 
39.1–40.8, range of 16–68 years), and 30.8% were aged 
35–54  years (Fig.  2). Unadjusted estimates of antigen 
and antibody prevalence for all age groups are shown 
in Fig. 2.
The age distribution of sampled participants was pre-
viously shown to be similar to the distribution in the 
working population [2], but different to the general 
population (Additional file  1: Figure S1). Due to zero 
positives in some 10-year age groups, age-adjusted 
prevalence was estimated using two age groups: 15–34 
and ≥ 35  years. Because the sampled population was 
older than the general adult population, the overall 
prevalence of antigen after adjustment for age was 1.5% 
compared to crude prevalence of 1.8%.
Antibody prevalence (any antibody) was lowest in age 
group 25–34  years in both genders. Compared to age 
group 15–24  years, Bm14 antibody prevalence was sig-
nificantly higher in age group 35–44 years (Table 2).
Ethnicity
The participants were predominantly Samoan (97.5%). 
Other ethnicities were Filipino (1.1%), Tongan (0.9%), 
Tokelau (0.5%), Fijian (0.3%) and Caucasian (0.3%) 
(n = 646 with ethnicity data). There was no significant 
association between any outcome variable and ethnicity, 
but the sample sizes for non-Samoans were very small.
Socioeconomic status characteristics
Socioeconomic status (SES)
Participants reported average annual household 
income in four categories: less than USD 10,000 (51.1% 
of households); USD 10,000–20,000 (35.7%); USD 
20,000–30,000 (7.5%); and over USD 30,000 (5.7%). Due 
to a substantial proportion of people not knowing or 
preferring not to answer this question, information was 
available from only 466 (69.6%). The asset index based 
on 9 household items was obtained for 646 households 
out of a possible 670. The distribution of asset index 
scores and the relationship between the asset index 
and the reported annual income category are shown 
in Additional file 1: Figures S2, S3. To achieve the most 
complete household data, SES level was used based on 
asset index divided into three quantiles: low; medium; 
and high.
For household characteristics, 71.1% and 77.0% of 
households had indoor toilet and shower, respectively, 
13.4% had piped hot water, and 81.3% had garbage col-
lection. Ceiling fans were present in 92.0% of households 
but only 23.0% had air-conditioning; 92% of households 
owned a TV. The asset index included possession of two 
items (window screens and mosquito nets) related to vec-
tor control (although these may have limited relevance 
for predominantly day biting vectors). Some windows or 
doors were screened in 91.1% of households, while only 
28.7% of households possessed at least one mosquito net. 
The mean number of nets per household was only 0.6 
(range 0–8 nets per household) and the mean number of 
nets per person was 0.1.
There were no antigen-positives among persons in the 
highest SES quantile, compared to 2.6% and 2.4% in the 
lowest and medium quantiles, respectively. Antibody 
Table 1 Prevalence of antigen and antibody, by sampling site and overall
Abbreviations: Ag: antigen (ICT and/or Og4C3); n, no. positive; N, no. tested












Cannery 1.6 (0.7–3.1) 8/498 12.5 (9.7–15.7) 62/497 12.7 (9.9–15.9) 63/497 18.3 (15.0–22.0) 91/497 18.5 (15.2–22.2) 92/497
Clinic 2.3 (0.6–5.8) 4/172 10.1 (6.0–15.6) 17/169 7.1 (3.7–12.1) 12/169 14.2 (9.3–20.4) 24/169 14.8 (9.8–21.1) 25/169
Total 1.8 (0.9–3.1) 12/670 11.9 (9.5–14.6) 75/666 11.3 (9.0–13.9) 75/666 17.3 (14.5–20.4) 115/666 17.6 (14.8–20.7) 117/666
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prevalence (both Bm14 and Wb123) was highest in the 
lowest SES quantile and lower in those living in house-
holds of medium and high SES (Fig. 3, Table 2).
Household size
Participants reported an average of 6.2 persons in their 
households (range 1–30); 58.8% of households were small 
(≤ 6 persons) and 41.2% had more than 6 persons. There 
was no association between household size and either 
antigen or antibody positivity (Table 2).
Educational level
In American Samoa, school attendance is mandatory 
for residents and comprises primary, junior secondary, 
and senior secondary levels, but migrants may not have 
attained the same educational level. There is also a post-
secondary community college on Tutuila. Only 0.6% (4 
persons) had no formal education, 2.8% (18) had only pri-
mary level education and 6.5% (42) only completed junior 
secondary. The remaining participants completed senior 
























































































Fig. 2 Age- and gender-specific prevalence of antigen and antibody
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Overall, 90.1% completed senior secondary school or 
higher-level education. Univariate analysis suggested 
a higher Bm14 antibody prevalence in those who had a 
lower level of education, but this was not statistically sig-
nificant (Table 2).
Work status and location
Participants were asked about the location (indoors, out-
doors or mixed) of their current job and of any other job 
they had held in the past year. Overall, 99.8% (of 574) 
had a job in the past year, which is not surprising since 
the majority were recruited at a work site (cannery) or 
employment clinic. Of those with known work history 
36 (6.3%) and 3 (0.5%) had a second or third job in the 
past year, respectively, and only three people (0.5%) had 
a job in Samoa in the past year. The great majority of 
jobs (93.4%) were conducted indoors; only 1.2% and 5.4% 
were outdoors or mixed locations, respectively (n = 572). 
There was a tendency towards higher Wb123 antibody 
prevalence in those who worked outdoors (Table 2).
Table 2 Univariate analysis of demographic and socioeconomic risk factors affecting antigen and antibody positivity
# not significant (Fisher’s exact test), ## P < 0.04 by Fisher’s exact test comparing High vs Med+Low SES
*P < 0.2, **P < 0.1, ***P < 0.05, ****P < 0.01
Abbreviations: Ag: antigen (ICT and/or Og4C3); n, no .positive; N, no. tested; na, not available (zero cases); Snr 2ndary, senior secondary; per decr, per decreasing; Ref, 
reference category
Factor Level Ag Bm14 Ab Wb123 Ab Any Ab
% positive (n) OR (95% CI) % positive 
(n)
OR (95% CI) % positive (n) OR (95% CI) % positive (n) OR (95% CI)
Sampling site Cannery 1.61 (498) 12.47 (497) 12.68 (497) 18.31 (497)
Clinic 2.33 (172) 1.46 (0.43–
4.90)
10.06 (169) 0.78 (0.44–
1.38)
7.10 (169) 0.53 (0.28–
1.00)**
14.20 (169) 0.74 (0.45–
1.20)










15–24 1.14 (88) Ref 6.98 (86) Ref 11.63 (86) Ref 16.28 (86) Ref
25–34 1.63 (123) 1.44 (0.13–
16.11)
4.92 (122) 0.69 (0.21–
2.22)
5.74 (122) 0.46 (0.17–
1.27)*
8.20 (122) 0.46 (0.19–
1.09)**
35–44 2.54 (197) 2.27 (0.26–
19.68)
16.75 (197) 2.68 (1.08–
6.67)***
13.71 (197) 1.21 (0.56–
2.62)
22.34 (197) 1.48 (0.76–
2.87)
45–54 1.94 (206) 1.72 (0.19–
15.64)
12.68 (205) 1.94 (0.77–
4.89)*
13.66 (205) 1.20 (0.56–
2.60)
18.05 (205) 1.13 (0.58–
2.22)
> 55 0 (56) na 14.29 (56) 2.22 (0.73–
6.79)*
5.36 (56) 0.43 (0.11–
1.64)
17.86 (56) 1.11 (0.46–
2.73)
Gender Female 1.26 (398) 7.09 (395) 6.84 (395) 10.89 (395)
Male 2.83 (247) 2.30 (0.72–
7.30)*
18.62 (247) 3.00 (1.82–
4.95)****
17.81 (247) 2.95 (1.78–
4.91)****
26.72 (247) 2.98 (1.95–
4.56)****
Ethnicity Non-Samoan 0 (16) # 12.50 (16) 12.50 (16) 25.0 (16)
Samoan 1.90 (630) na 11.80 (627) 0.94 (0.21–
4.20)
11.32 (627) 0.89 (0.20–
4.01)
17.07 (627) 0.62 (0.19–
1.95)












Low 2.59 (232) ## 14.29 (231) 1.63 (0.86–
3.12)
13.85 (231) 2.21 (1.08–
4.52)***
21.65 (231) 2.08 (1.17–
3.68)***
Medium 2.38 (252) na 11.20 (250) 1.24 (0.64–
2.40)
11.60 (250) 1.80 (0.87–
3.72)*
16.4 (250) 1.48 (0.82–
2.65)*
High 0 (162) 9.26 (162) Ref 6.79 (162) Ref 11.73 (162) Ref
Persons per 
house








Education Snr 2ndary or 
higher
2.07 (580) # 10.92 (577) 10.75 (577) 16.46 (577)
< Snr 2ndary 0 (64) na 17.19 (64) 1.69 (0.84–
3.41)*
12.50 (64) 1.19 (0.54–
2.60)
20.31 (64) 1.29 (0.68–
2.47)
Work location Indoor 1.69 (534) # 11.63 (533) 11.07 (533) 16.7 (533)
Outdoor or 
mixed
0 (38) na 18.42 (38) 1.72 (0.72–
4.06)
18.42 (38) 1.81 (0.76–
4.30)*
26.32 (38) 1.78 (0.84–
3.80)*
Page 8 of 18Graves et al. Parasites Vectors          (2020) 13:125 
Residence and mobility
Village and county of residence
Household locations of the participants were distributed 
throughout the islands of Tutuila and Aunu’u and are 
shown in relation to village boundaries in Fig.  4, which 
also shows the locations of the cannery and DOH clinic.
Participants lived in a total of 50 different villages (out 
of 74 total villages) spread across the islands of Tutuila 
and Aunu’u, with 1–63 participants per village. Although 
the cannery is located in Atu’u village, only two partici-
pants actually lived there, and most commuted from else-
where on the two islands.
American Samoa has nine counties on Tutuila and 
Aunu’u; our study included 14–232 participants per 
county. The county of residence was assigned to each 
participant, to investigate whether the sample was rep-
resentative of the general population. The results given 




















Fig. 3 Prevalence of antigen or antibody, by SES quantile
Fig. 4 Household locations of participants recruited at worksite and clinic
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persons sampled was proportional to the population by 
county.
Prevalence of antigen and antibody varied by county 
(Additional file 1: Figure S5), with Tualatai county (mid-
west and south of Tutuila island) having lowest preva-
lence of all markers while Leasina (further west) and 
Sua (east) counties had the highest antibody prevalence. 
County was not significant in univariate analysis but was 
included in multivariate models (see below).
Duration of residence in American Samoa
Only 28.9% of participants stated that they had lived 
in American Samoa their whole life, but the majority 
(70.4%) had lived there for more than 14  years. Smaller 
but similar proportions had lived in American Samoa for 
9–14 years (13.7%) and less than 9 years (15.9%).
Antibody prevalence was highest in persons who 
had lived in American Samoa for 9–14  years (Fig.  5, 
Table  3). While these were not necessarily continuous 
years before the survey, they most likely represent the 
time period from 2000 to 2005, i.e. during the years 
of MDA, which continued until 2006. Those reporting 
> 14  years residence were likely in American Samoa 
for the full duration of MDA. Those who reported 
residence of less than 9  years most likely missed the 
MDA period in American Samoa (but might have par-
ticipated elsewhere) and any exposure to infection in 
American Samoa was probably after MDA had stopped 
(or occurred elsewhere).
Travel history
The great majority (88.9%) of the population had been 
outside of American Samoa (n = 649) at least once 
in their lives. Those who had ever travelled outside 
American Samoa had higher prevalence of Bm14 or any 
antibody (Table  3), but these differences were not sta-
tistically significant.
In the 12 months before our study, 38.0% of partici-
pants had travelled outside the Territory. Of these, 33.6% 
went to Samoa, 4.6% to other countries that were LF 
endemic at that time (Fiji, Tonga and Palau) and 9.9% to 
non-endemic overseas destinations (Hawaii, mainland 
USA, New Zealand, Australia, Japan). Some travellers 
made multiple overseas trips (mean 1.45, range 1–6 [2]), 
so the proportion of persons traveling to either Samoa 
or other endemic countries in the last year was 35.0%. 
In addition, 40.7% of households received visitors (who 
stayed at least one night) from Samoa in the last year. 
Most outward trips and inward visits were of one week to 
one month duration but ranged from less than a week to 
more than 6 months [2].
Travel to other endemic countries
The proportion of antigen-positive persons who had 
travelled to other endemic countries (mainly Samoa) in 
the last 12 months was 33.3%, in line with the overall 
sample. There was no increase in antigen or antibody 






















Fig. 5 Antigen and antibody positivity, by residence time in American Samoa
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travelled to other endemic countries (mainly Samoa) in 
the past year (Table 3, Additional file 1: Figure S6).
Travel to non‑endemic countries
None of the people who had travelled to non-endemic 
countries in the last year was antigen-positive (Table 3, 
Additional file 1: Figure S6), compared to 2.1% in those 
who had not undertaken such travel. Prevalence of anti-
body positivity was lower in participants who had trav-
elled to non-endemic countries in the last 12 months, 
but these differences were not statistically significant 
(Table 3).
Hosting visitors from Samoa
There was no difference between antigen or antibody 
positivity in persons living in households that had 
received overnight visitors from Samoa in the past year 
(Additional file 1: Figure S6, Table 3).
Participation in MDA and knowledge of lymphatic filariasis
MDA participation
MDA has been offered repeatedly in both Samoa and 
American Samoa in the last 20 years, but not for ~ 8 
years prior to this survey in American Samoa. Given 
the time elapsed, participants were reminded of the 
free MDA programmes run by the government, DOH 
and churches and asked ‘did you take tablets through 
this programme in American Samoa?’ or similarly ‘… 
in any other countries?’. Participants’ responses indi-
cated that 62.1% had previously taken MDA in Ameri-
can Samoa (last round was in 2006) and 21.5% had 
taken it elsewhere, most likely Samoa (last nationwide 
round in 2011). Overall, 68.8% of persons reported 
taking MDA in either American Samoa or elsewhere 
(n = 618). Females were more likely to have taken MDA 
in the past (71% of 383 females vs 65% of 231 males) 
but this was not statistically significant (χ2 = 2.147, 
df = 1, P = 0.143). There was no difference in antigen or 
antibody prevalence by prior MDA status (Table 4 and 
Additional file 1: Figure S7).
Heard of LF
Overall, 84.0% (544) of the sampled population had 
heard of LF, out of the 648 who responded to this ques-
tion. Participants age 25 and over were more likely to 
have heard of LF than younger participants (86.5% of 
564 persons ≥ 25  years vs 66.7% of 84 under 25  years; 
χ2 = 21.398, df = 1, P < 0.001).
Table 3 Univariate analysis of residence and mobility/travel risk factors affecting antigen and antibody positivity
*P < 0.2, **P < 0.1, ***P < 0.05, ****P < 0.01, # not significant (Fisher’s exact test)
a In last 12 months
Abbreviations: Ag: antigen (ICT and/or Og4C3); AS, American Samoa; n, no. positive; N, no. tested; na, not available (zero cases); ref, reference category
Factor Level Ag Bm14 Ab Wb123 Ab Any Ab
% positive (n) OR (95% CI) % positive (n) OR (95% CI) % positive (n) OR (95% CI) % positive (n) OR (95% CI)
Years lived 
in AS
< 9 2.91 (103) Ref 8.74 (103) Ref 12.62 (103) Ref 15.53 (103) Ref
9–14 2.25 (89) 0.77 (0.13–
4.69)
19.10 (89) 2.47 (1.04–
5.85)***
17.98 (89) 1.52 (0.69–
3.36)
25.84 (89) 1.89 (0.93–
3.87)**
> 14 1.54 (456) 0.52 (0.13–
2.04)
10.82 (453) 1.27 (0.60–
2.67)
9.49 (453) 0.73 (0.37–
1.41)
15.67 (453) 1.01 (0.56–1.82)
Ever been 
outside AS
No 2.78 (72) 6.94 (72) 9.72 (72) 11.11 (72)
Yes 1.72 (577) 0.62 (0.13–
2.87)
12.37 (574) 1.89 (0.74–
4.85)*
11.50 (574) 1.21 (0.53–
2.74)




No 1.86 (431) 12.12 (429) 11.66 (429) 17.72 (429)
Yes 1.83 (218) 0.99 (0.29–
3.32)
11.06 (217) 0.90 (0.54–
1.51)
10.60 (217) 0.90 (0.53–
1.52)
16.13 (217) 0.89 (0.58–1.38)
Visitor from 
 Samoaa
No 1.83 (383) 12.34 (381) 11.55 (381) 17.59 (381)
Yes 1.90 (263) 1.04 (0.33–
3.32)
11.07 (262) 0.88 (0.54–
1.45)
11.07 (262) 0.95 (0.58–
1.57)




No 1.90 (421) 12.41 (419) 11.69 (419) 17.90 (419)
Yes 1.76 (227) 0.93 (0.28–
3.11)
10.62 (226) 0.84 (0.50–
1.40)
10.18 (226) 0.86 (0.51–
1.45)




No 2.05 (584) # 12.18 (583) 11.66 (583) 17.50 (583)
Yes 0.00 (64) na 8.06 (62) 0.63 (0.25–
1.63)
6.45 (62) 0.52 (0.18–
1.48)
12.90 (62) 0.70 (0.32–1.51)
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Diagnosis of LF
In this sample, eight people (1.5% of those who had heard 
of LF) aged between 31–54 years reported that a health 
worker had previously diagnosed them with LF, with year 
of diagnosis between 1989 and 2012 for five persons and 
unspecified for three persons. All eight were negative 
for antigen and Bm14, but two were positive for Wb123 
antibody.
Symptoms of LF
Among those who had heard of LF before our study, over 
a third (37.3%) were unsure of any symptoms of LF. The 
unprompted response most frequently given was ‘swol-
len limb’ (46.9%). Very few people mentioned hydrocoele 
or swollen scrotum (1.7%). Summarised responses are 
shown in Additional file  1: Table  S1. Participants aged 
25 years or over were more knowledgeable about ‘any 
symptom of LF’ (55.3% of 564 ≥ 25  year-olds were able 
to correctly name a symptom of LF vs 40.1% of 84 under 
25 year-olds; χ2 = 6.473, df = 1, P = 0.011) but differences 
were not significant for specific symptom categories. 
Females had slightly higher knowledge of all symptoms 
than males for most variables, but none of the differences 
was statistically significant.
Antigen and antibody prevalence were lower in those 
who knew that chronic symptoms (swelling/genitou-
rinary symptoms or skin changes) were related to LF 
(Fig. 6). The association between lower prevalence of any 
antibody with a combined measure of ‘knowing chronic 
symptoms’ was statistically significant (Table  4). Con-
versely, prevalence of antigen was significantly higher in 
those who mentioned fever and pain (classified as ‘acute 
symptoms’) (Fig. 6 and Table 4).
Causes of LF
Among those who had heard of LF, over a quarter (28.7%) 
were not able to provide any answer about the cause of 
the disease. Two-thirds (67.5%) of persons who had 
heard of LF stated the cause to be mosquito bite. Direct 
infection or unclean environment were mentioned by a 
minority of people. Summarised responses are shown in 
Additional file 1: Table S2. There was no significant dif-
ference between males and females in knowledge about 
mosquito bite as the cause of LF (65.0% of 203 males vs 
Table 4 Univariate analysis of MDA participation, diagnosis and knowledge risk factors affecting antigen and antibody positivity
*P < 0.2, **P < 0.1; ***P < 0.05; ****P < 0.01; # not significant (Fisher’s exact test)
Abbreviations: Ag: antigen (ICT and/or Og4C3); n, no. positive; N, no. tested; na, not available (zero cases)
Factor Level Ag Bm14 Ab Wb123 Ab Any Ab
% positive (n) OR (95% CI) % positive (n) OR (95% CI) % positive (n) OR (95% CI) % positive (n) OR (95% CI)
MDA Never taken 2.60 (192) 9.90 (192) 11.98 (192) 15.63 (192)
Taken (any-
where)
1.41 (426) 0.53 (0.16–
1.77)
12.50 (424) 1.30 (0.75–
2.26)
10.61 (424) 0.87 (0.51–
1.49)





No 1.46 (616) # 11.89 (614) # 11.07 (614) 17.10 (614)
Yes 0.00 (8) na 0.00 (8) na 25.00 (8) 2.68 (0.53–
13.52)






No 2.42 (289) 12.46 (289) 12.80 (289) 19.38 (289)
Yes 0.78 (255) 0.32 (0.07–
1.55)*
10.63 (254) 0.84 (0.49–
1.42)
9.84 (254) 0.74 (0.43–
1.27)




No 1.84 (434) 12.24 (433) 11.32 (433) 18.24 (433)
Yes 0.91 (110) 0.49 (0.06–
3.95)
9.09 (110) 0.72 (0.35–
1.46)
11.82 (110) 1.05 (0.55–
2.01)




No 2.49 (241) 13.69 (241) 13.28 (241) 21.16 (241)
Yes 0.99 (303) 0.39 (0.10–
1.58)*
9.93 (302) 0.70 (0.41–
1.18)*
9.93 (302) 0.72 (0.42–
1.22)




No 1.11 (451) 11.09 (451) 11.31 (451) 16.85 (451)
Yes 4.30 (93) 4.01 (1.06–
15.22)***
14.13 (92) 1.32 (0.68–
2.54)
11.96 (92) 1.07 (0.53–
2.13)




No 1.52 (198) 12.63 (198) 13.64 (198) 20.71 (198)
Yes 1.73 (346) 1.15 (0.28–
4.64)
11.01 (345) 0.86 (0.50–
1.47)
10.14 (345) 0.72 (0.42–
1.22)





No 1.69 (177) 15.25 (177) 16.38 (177) 24.29 (177)
Yes 1.63 (367) 0.96 (0.24–
3.90)
9.84 (366) 0.61 (0.35–
1.03)**
9.02 (366) 0.51 (0.30–
0.86)***
14.21 (366) 0.52 (0.33–
0.81)***
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68.6% of 338 females who had heard of LF; χ2 = 0.753, 
df = 1, P = 0.386). Knowledge that mosquitoes transmit 
LF was associated with significantly lower prevalence of 
Wb123 (OR = 0.51, 95% CI: 0.30–0.86, P = 0.013) and of 
any antibody (OR = 0.52, 95% CI: 0.33–0.81, P = 0.004) 
(Fig. 7 and Table 4).
Multivariate regression analysis
Three models were tested with all four outcomes. The 
results of MODEL A (all participants; knowledge vari-
ables assigned to ‘no’ if person had not heard of LF) 
are shown in Table  5. Results for MODEL B (omitting 
knowledge variables to maximise sample size, Additional 









































Fig. 6 Antigen and antibody prevalence, by knowledge of LF symptoms
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including only those who reported knowing about LF, 
Additional file  1: Table  S4) were similar to MODEL A 
(Table 5), with minor differences in adjusted odds ratios 
(aOR) or P values, or wider confidence intervals (for 
MODEL C). Variables were included in the final models 
if they had a P value < 0.2, or if their inclusion markedly 
affected the aOR of other factors or the overall model fit. 
We assessed the impact of including county as a fixed 
effect in all models, to account for unmeasured geo-
graphical or other variation and found that it decreased 
the log likelihood in sequential models as well as increas-
ing the likelihood ratio and pseudo-R2 by at least 25% and 
up to > 100%. Therefore aORs, 95% confidence intervals 
and P-values reported in Table 5 and in Additional file 1: 
Tables S3 and S4 are for models including county.
Antigen
The number of antigen-positives in the sample (n = 12) 
was small, limiting the power of analysis with this out-
come. After adjusting for covariates, factors asso-
ciated with increased antigen positivity were male 
gender (aOR = 2.64, 95% CI: 0.78–8.94), lower SES level 
(aOR = 2.89 per level, 95% CI: 1.09–7.69) and knowledge 
of acute symptoms (fever and/or pain) that can be due to 
LF (aOR = 3.53, 95% CI: 0.98–12.74) (Table 5). Sampling 
site (aOR = 2.52, 95% CI: 0.65–9.75 for clinic vs can-
nery site) was also retained in the model. Knowledge of 
some chronic LF symptoms (swelling, hydrocoele and/or 
chyluria) was associated with lower prevalence of antigen 
(aOR = 0.29, 95% CI: 0.06–1.41).
Antibody
For Bm14 antibody, all age groups above 35  years had 
higher prevalence compared to 15–24  year-olds, with 
aOR of 3.75, 3.76 and 4.17 (all P < 0.05) for ages 35–44, 
45–54 and ≥ 55 years, respectively (Table 5). Other sig-
nificant factors retained in the model for Bm14 preva-
lence were male gender (aOR = 3.44, 95% CI: 2.04–5.82), 
lower SES quantile (aOR = 1.30 per quantile, 95% CI: 
0.92–1.84) and years of residence in American Samoa 
(highest in those residing for 9–14 years, compared to < 9 
years, aOR = 2.26, 95% CI: 0.89–5.72). Knowing that 
mosquitoes transmit LF was associated with lower Bm14 
antibody prevalence (aOR = 0.65, 95% CI: 0.38–1.09) 
(Table 5).
Wb123 antibody prevalence showed similar posi-
tive associations with male gender (aOR = 3.63, 95% 
CI: 2.11–6.27) and lower SES quantile (aOR = 1.46, 
95% CI: 1.02–2.11) (Table  5). Other factors retained 
in the model that were negatively associated with 
Wb123 prevalence were sampling site (aOR = 0.52, 
95% CI: 0.24–1.13 for clinic vs cannery) and knowl-
edge that mosquitoes transmit LF (aOR = 0.55, 95% CI: 
0.32–0.95).
For ‘any antibody’ (either or both Bm14 or Wb123), 





















Fig. 7 Antigen and antibody prevalence, by knowledge that mosquitoes transmit LF
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again male gender (aOR = 3.49, 95% CI: 2.21–5.49), lower 
SES quantile (aOR = 1.51, 95% CI: 1.12–2.05) and years 
lived in American Samoa (aOR = 2.00, 95% CI: 0.91–4.40 
for 9–14 years). Other factors retained were having ever 
travelled outside American Samoa (aOR = 1.80, 95% CI: 
0.75–4.32) (although not travel or visitors in the last 12 
months) and knowledge of acute symptoms (aOR = 1.60, 
95% CI: 0.86–2.95). As for the individual antibody 
seromarkers, knowledge that mosquitoes transmit LF 
was associated with lower prevalence of any antibody 
(aOR = 0.56, 95% CI: 0.36–0.90).
Discussion
Elimination of lymphatic filariasis as a public health 
problem is proving to be a challenge for GPELF in some 
countries. Despite MDA programmes [7] similar to 
those that successfully achieved validation of elimina-
tion in several PacELF countries, including Vanuatu 
[25], Niue [26] and Tonga [27], American Samoa has 
not yet achieved this milestone, even though prevalence 
fell to low levels by 2007 [10, 28, 29]. The processes for 
post-MDA surveillance and monitoring are not yet well 
defined, resource intensive and may fall by the wayside 
in the face of competing priorities. It is not clear that 
Table 5 MODEL A: multivariate logistic regression of risk factors affecting LF antigen and antibody positivity: sociodemographic, 
residence and knowledge covariates, all participants (n = 638–641)
*P < 0.2, **P < 0.1, ***P < 0.05, ****P < 0.01
Abbreviations: Ag: antigen (ICT and/or Og4C3); AS, American Samoa; n, no. positive; N, no. tested; na, not available (zero cases); Ref, reference category; inc., including; 
LR, likelihood ratio
Factor Level Ag (n = 641) Bm14 Ab (n = 641) Wb123 Ab (n = 638) Any Ab (n = 638)
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Sampling site Clinic vs Cannery 2.52 (0.65–9.75)* 0.182 0.52 (0.24–
1.13)**
0.099
Age group (years) 15–24 Ref Ref Ref
25–34 1.21 (0.32–4.61) 0.779 0.64 (0.21–1.94) 0.431 0.55 (0.21–1.42) 0.219
35–44 3.75 (1.21–
11.63)***
0.022 1.36 (0.54–3.40) 0.511 1.46 (0.67–3.19) 0.342
45–54 3.76 (1.22–
11.67)***
0.022 1.70 (0.69–4.21) 0.252 1.38 (0.62–3.05) 0.427
> 55 4.17 (1.12–
15.51)***
0.033 0.63 (0.15–2.70) 0.536 1.35 (0.49–3.72) 0.557
Gender Male vs female 2.64 (0.78–8.94)* 0.118 3.44 (2.04–
5.82)****
< 0.001 3.63 (2.11–
6.27)****
< 0.001 3.49 (2.21–
5.49)****
< 0.001
SES quantile Per decr. quantile 2.89 (1.09–
7.69)***





Years lived in AS < 9 Ref Ref Ref
9–14 2.26 (0.89–5.72)** 0.086 1.62 (0.67–3.90) 0.283 2.00 (0.91–
4.40)**
0.083
> 14 1.22 (0.55–2.70) 0.624 0.76 (0.37–1.57) 0.462 1.12 (0.58–2.13) 0.741
Ever been out-
side AS
Yes vs no 1.80 (0.75–4.32)* 0.190
Know swelling or 
genitourinary 
symptom
Yes vs no 0.29 (0.06–1.41)* 0.125
Know acute 
symptoms
Yes vs no 3.53 (0.98–
12.74)**
0.054 1.60 (0.86–2.95)* 0.135
Know mosquito 
as cause







< 0.001 0.02 (0.003–
0.09)****
< 0.001 0.07 (0.02–
0.32)****
< 0.001 0.03 (0.01–
0.13)****
< 0.001
Log-likelihood − 52.969305 − 206.46537 − 197.11102 − 259.59574
Log-likelihood 
(inc. county)
− 48.999694 − 200.41316 − 190.39068 − 253.82438
LR Chi-square 21.25** 0.068 57.07**** < 0.001 60.62**** < 0.001 72.60**** < 0.001
Pseudo R2 0.1782 0.1246 0.1373 0.1251
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the current recommendations for transmission assess-
ment surveys (TAS) in 6–7 year-old children are sen-
sitive enough to pick up resurgent transmission until 
prevalence has reached high levels, and/or when trans-
mission has become widespread. After MDA stopped in 
2006, no TAS were done in American Samoa until 2011, 
and although TAS-1 in 2011 and TAS-2 in 2015 officially 
‘passed’ the WHO targets [9], the same was not true for 
TAS-3 in 2016 which showed prevalence had clearly 
increased [13], necessitating restarting MDA with three 
drugs in 2018.
In the light of the current situation, we present further 
results from a research survey done in 2014 [12] using 
a different approach to routine post MDA surveillance, 
i.e. testing at-risk adults at work (rather than home) set-
tings. The approach of testing adults, although not at 
work sites, has also been reported by Rao et al. [30] in Sri 
Lanka. The present study demonstrates the value of tar-
geted surveys of working adults for efficiently providing 
representative information about LF prevalence and risk 
factors without the necessity of costly and time-consum-
ing household cluster surveys, as have been done in many 
other LF endemic countries to monitor progress [31–33].
The present study confirms the highly important risk 
factor of gender for LF infection, with males at more than 
three times higher risk for antibodies. Regarding age, our 
sample was working-age adults only (16–68 years), with 
3- to 4-fold higher prevalence of Bm14 antibody in age-
groups over 35. The increased prevalence of LF in males 
is frequently observed worldwide, including in American 
Samoa [10–13] but the reasons for it are not clear. Vari-
able exposure (e.g. increased working outside by males) 
alone is not likely to account for the difference [34], espe-
cially in a population engaged in a predominantly indoor 
occupation as in this study.
For socioeconomic status (SES), prevalence of antigen 
increased almost three-fold and prevalence of Wb123/
any antibody increased ~ 1.5 times per SES quantile level 
decrease. Prior MDA (not offered in American Samoa 
since 2006 but available in Samoa in more recent years), 
educational level, and outdoor work location were not 
associated with presence of antigen or antibody.
There was no increased risk of LF in those who travelled 
to Samoa or other endemic areas in the last 12 months, 
or those who had household visitors from Samoa. There 
was also no significant decreased risk in those who had 
travelled to non-endemic areas in the last 12 months 
(mainly to Hawaii or mainland USA). The importance 
of these findings relate to the possibility of reintroduc-
tion or exportation of LF parasites through population 
mobility [2] and hence prediction of the likely success of 
LF elimination programmes. The prevalence in Samoa at 
the time of this survey was unknown, but it appears that 
importation of parasites from neighbouring countries 
(e.g. Samoa) was not a major risk factor at the time of the 
present study. A plausible explanation for this finding is 
that the two Samoas represent a single transmission zone 
(common pool of infection) with little difference between 
them in the persisting risk of infection [35]. At present, 
it may not be necessary to include parasite importation 
in spatial transmission models for American Samoa [36]. 
Both countries embarked in 2018 on simultaneous triple-
drug MDA programmes, but if the synchronization of 
this slips, elimination in one Samoa will potentially be 
jeopardized by importation of parasites from the other in 
future.
A community-based study of adults in 2010 [11] 
observed higher prevalence in those who had lived in 
American Samoa for less than 5 years (compared to 
longer). In contrast, four years later in 2014, we did not 
find significantly higher seroprevalence in those who 
had lived a shorter time (< 9  years) in American Samoa 
compared to those who had lived there for 9–14 years 
or longer. The time periods were chosen in relation to 
stopping of annual MDA programmes in 2005–2006 in 
both Samoas. At the end of these programmes, antigen 
prevalence was at historically low levels [3, 10]. Those 
living in American Samoa for 9–14 years prior to 2014 
had the highest prevalence of antibodies in the present 
study; they would likely have lived through some of the 
MDA years and received treatment, but still have per-
sisting antibodies. Those residing in American Samoa 
longer than 14 years may also have received treatment 
from MDA during 2000–2006, but perhaps acquired 
infections earlier on average, and may be now losing their 
serological markers of infection. Further investigation of 
changing transmission conditions over the time period 
2010–2016 and beyond is underway by modelling studies 
[36].
The sero-epidemiological study in 2010 [11] reported 
prevalence of antigen and antibodies in a sample of 
adults recruited at home; at that time antigen preva-
lence by Og4C3 ELISA was 3.2%. The antigen prevalence 
observed in the present study in adults (1.9% after adjust-
ing for gender and age) was lower than in 2010, although 
this difference was not statistically significant (P = 0.08). 
A trend towards lower prevalence in the present study 
than 2010 may be due to sampling the healthy working 
population (with possibly lower exposure to mosquitoes) 
rather than the overall population in the community set-
ting, which would include those unable to work due to 
LF or other disability. Even if the prevalence in working 
adults is an underestimate of overall adult prevalence, the 
results (together with the signals from the survey in 2010 
[11]) could nevertheless have provided early warning of 
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ongoing and resurgent transmission that was not identi-
fied by TAS until 2016 [13].
In the present survey, 84.0% of participants had heard 
of LF. This was similar to the 82.4% who had heard of LF 
in a community knowledge, attitudes and practice survey 
pre-MDA in 2003, but was a lower proportion than the 
95.4% reported in an independent coverage survey after 
the 2004 MDA [7]. Over one-third of participants in our 
study could not describe any symptoms, and over a quar-
ter were not able to provide answers about the cause of 
LF. It is possible that the long time elapsed since the last 
MDA in 2006 could have resulted in these low levels of 
knowledge, especially in the younger adults.
Knowledge of acute symptoms of LF was associated 
with higher antigen prevalence, while those who men-
tioned swelling or genitourinary symptoms of LF were 
less likely to be antigen-positive. The most common 
cause of LF mentioned by two-thirds of people was ‘mos-
quito bite’ and this knowledge was associated with lower 
prevalence of Bm14 and Wb123 antibodies. Knowledge 
of mosquito transmission of LF has previously been asso-
ciated (among many other factors) with increased likeli-
hood of taking MDA (reviewed in [37]). This knowledge 
may reduce LF prevalence by increasing MDA participa-
tion, but it is also possible that knowledge about the dis-
ease contributed to preventive measures against infective 
mosquito bites in the past.
Previously reported successful efforts to improve 
community participation in MDA in American Samoa 
included innovative communication methods to fill gaps 
in knowledge [7], but a long time has elapsed since 2004, 
and younger people would not have heard these mes-
sages or seen many people with LF morbidity. Learning 
from these former efforts and current findings to raise 
public knowledge of the symptoms and causes might 
lead to increased participation in the control programme 
and MDA in future, thus averting resurgence to pre-2000 
prevalence levels.
The study has some limitations. First, a working (or 
work-seeking) population likely excludes those of lowest 
socioeconomic status and/or those who are disabled and 
unable to work, and is biased towards those with higher 
income. Nevertheless, we were able to stratify the sam-
ple by SES even in this relatively affluent population. A 
working population may include a higher proportion of 
recent migrants than the general population, although 
most of our participants had been in American Samoa 
for many years. These factors would have tended to bias 
the results towards lower prevalence of seromarkers and 
reduced likelihood of finding associations. The conveni-
ence nature of the sample was necessitated by opportun-
istic recruitment at the clinic and at the cannery during 
shift breaks, and lack of availability of full employee lists. 
The sample age distribution was reflective of the general 
working population, but was generally older and more 
biased towards females than the general adult popula-
tion. Prior MDA participation (taking the tablets) was 
self-reported, and the MDA programme (conducted 
8–13 years ago) did not insist on directly observed treat-
ment at that time. We assessed travel history in the last 
12  months, but seromarkers persist for many years and 
could have been acquired more than 12 months ago. We 
regard the 12-month period as a proxy marker for usual 
frequency of travel by participants.
Our sample was 97.5% Samoan, whereas the cen-
sus 2010 [1] reported that only 85% of the population 
was ethnically Samoan. The prevalence of filariasis is 
unknown in the poorly sampled non-Samoan popula-
tion who may be less likely to work in the formal sector. 
Efforts should be made to include them in future surveys.
Our study was novel in including socioeconomic risk 
factors (as is usually done in malaria surveys [38]), as well 
as questions about residence, mobility and knowledge of 
LF, and the use of both antigen and multiple antibodies 
for LF as outcome variables. Another strength of the study 
was that the sample was representative of possible resi-
dential locations, including people from all over the main 
islands of Tutuila and Aunu’u, encompassing the range 
of sociodemographic and housing conditions across the 
territory (at both village [2] and county levels). Sampling 
at worksites generated close to a simple random sample 
of individuals, so this type of sampling avoids the neces-
sity of adjustment for village level clustering as needed 
for household cluster surveys. It was assumed that each 
worker lived in a different household; although it is pos-
sible that some workers (e.g. married couples) resided in 
the same household, this number is likely to be very small 
and have little influence on overall results. The workload 
was efficient since most of the participants were recruited 
over a very short time period (four days in the cannery, 
and added to the regular workflow on 14 specific days in 
the employment clinic over a 5-month period).
Conclusions
Opportunistic sampling of adults at worksites in 2014 
provided an efficient and representative way to assess 
prevalence and risk factors for LF in American Samoa. 
It confirmed the persistence of relatively high levels of 
infection compared to earlier surveys, and in hindsight, 
foreshadowed the resurgence of transmission confirmed 
by results from 2016. These findings suggest that cur-
rent post-MDA surveillance policy that relies solely 
on sequential TAS in 6–7  year-olds, with the poten-
tial of failing a third TAS many years after stopping 
MDA, should be reviewed. The risk of being infected 
with LF was not related to travel history or prior MDA 
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participation. Higher risk of infection assessed by one 
or more serological markers was associated with male 
gender, older age, lower SES, 9–14 years residence, 
knowledge of some chronic and acute symptoms and 
lack of knowledge about mosquito transmission. Future 
MDA should consider putting additional efforts towards 
achieving high drug coverage in relevant subpopulations 
such as adult males. To improve efficiency of surveil-
lance and prevent resurgence after MDA has stopped, 
programmes should consider specifically targeting these 
high-risk groups, leading to higher probability of finding 
infected people and hotspots of continuing transmission.
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